Citius Oncology, Inc. - Common Stock (CTOR)

Citius Oncology, Inc. is a biotechnology company focused on developing innovative therapies for cancer treatment

The company is dedicated to addressing unmet medical needs in oncology through its portfolio of proprietary drug candidates aimed at improving patient outcomes and enhancing the quality of life for those affected by cancer. Citius Oncology conducts advanced research and clinical trials to explore new treatment options, emphasizing the development of targeted therapies and combinations that leverage the immune system and novel mechanisms of action. Through its efforts, the company strives to contribute to the advancement of cancer care and expand available treatment modalities for patients enduring this challenging disease.